The results showed that the tumor size and volume were significantly (P < 0.01) decreased in lenti-PARP6 xenografts or sh-SNHG1 + lenti-PARP6 xenografts compared to those in the model (control) group (Figure 6(a)). This evidence concerns the gene PARP6 and neoplasm.